Cagrilintide copies a body signal
Cagrilintide is an altered, lab-made copy of amylin, a hormone—a body signal.
It is being studied for weight control.
- The body releases amylin when a person eats.
- Natural amylin helps with fullness and slows food leaving the stomach.
- These amylin facts come from the official information for a different medicine, pramlintide (Symlin). Some came from animal studies.
- They do not prove how cagrilintide works inside a person.
Peptide describes the material
Proteins and peptides use the same building blocks. A peptide links them in a short chain.
- The word describes how the substance is put together; it gives no answer about drug approval.
- Keep the ingredient question separate from the product question.
CagriSema is a combination
CagriSema pairs cagrilintide with semaglutide (Ozempic, Wegovy).
- Semaglutide copies a body signal from the gut, involved in appetite and blood sugar.
- Results for CagriSema belong to the combined treatment, not cagrilintide alone.
- When someone names a result, ask which product was studied.